Phase I Evaluation of Safety, Reactogenicity and Immunogenicity of Fractional-dose Inactivated Polio Vaccine (fIPV) Given Intradermally With Double Mutant Enterotoxigenic Escherichia Coli Heat Labile Toxin (dmLT) Adjuvant
Condition: Polio Interventions: Biological: dmLT; Biological: fIPV Sponsor: University of Vermont Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials